EC Orthopaedics

Purpose: The purpose of this case study is to demonstrate the efficacy of PRP in a patient with chronic pain and joint degeneration for whom conventional medicines were not helpful. PRP has shown to be a very effective modality for inflammation reduction in many tissue types over the past twenty years.

Methods: Physical Therapy treatment progression demonstrates the need for multiple interventions due to the patient’s physical deficits.

Results: The results are divided into four categories: AROM, Pain, Lower Extremity Functional Index score, and radiographic findings with significant improvements in all four categories.

Conclusion: The patient’s improvement was remarkable due to the administration of PRP, as this amount of improvement is typically not seen with just conventional Physical Therapy alone.

 Keywords: Platelet Rich Plasma; Talocrural Joint; Osteoarthritis

1. Boswell SG., et al. “Platelet-rich plasma: a milieu of bioactive factors”. Arthroscopy 3 (2012): 429-439.
2. Le A and Dragoo JL. “Orthobiologics: clinical application of platelet-rich plasma and stem cell therapy”. DeLee Drezs Orthop Sports Med. 5^th Elsevier XXXX: XXX.
3. Le AD., et al. “Platelet-rich plasma”. Clinics in Sports Medicine XX (2018): XX-XX.
4. Le AD., et al. “Current clinical recommendations for use of platelet-rich plasma”. Current Reviews in Musculoskeletal Medicine4 (2018): 624-634.
5. Machlus KR and Italiano JE Jr. “The incredible journey: From megakaryocyte development to platelet formation”. The Journal of Cell Biology 6 (2013): 785-796.
6. Di Michele M., et al. “Recent advances in platelet proteomics”. Expert Review of Proteomics4 (2012): 451-466.
7. Idzko M., et al. “Role of platelets in allergic airway inflammation”. The Journal of Allergy and Clinical Immunology 6 (2015): 1416-1423.
8. Speth C., et al. “Complement and platelets: mutual interference in the immune network”. Molecular Immunology1 (2015): 108-118.
9. Weyrich AS. “Platelets: more than a sack of glue”. Hematology/The Education Program of the American 0ociety of Hematology 1 (2014): 400-403.
10. Cozma CN., et al. “Platelet rich plasma-mechanism of action and clinical applications”. Journal of Clinical and Investigative Surgery 2 (2016): 41-46.
11. Fernandes L., et al. “EULAR Recommendations for the non-pharmacological core management - hip and knee osteoarthritis”. Annals of the Rheumatic Diseases7 (2013): 1125-1153.
12. Gato-Calvo L., et al. “Platelet-rich plasma in osteoarthritis treatment: review of current evidence”. Therapeutic Advances in Chronic Disease 10 (2019): 2040622319825567.
13. Guney A, et al. “Clinical outcomes of platelet rich plasma (PRP) as an adjunct to microfracture surgery in osteochondral lesions of the talus”. Knee Surgery, Sports Traumatology, Arthroscopy 8 (2015): 2384-2389.
14. Sun SF, et al. “Efficacy and safety of a single intra-articular injection of platelet-rich plasma on pain and physical function in patients with ankle osteoarthritis—a prospective study”. The Journal of Foot and Ankle Surgery4 (2021): 676-682.
15. , et al. “Platelet-rich plasma to treat ankle cartilage pathology - from translational potential to clinical evidence: a systematic review”. Journal of Experimental Orthopaedics 2 (2015): 2.
16. Tejero S., et al. “Conservative treatment of ankle osteoarthritis”. Journal of Clinical Medicine 19 (2021): 4561.
17. Yausepa OE., et al. “Platelet rich plasma for treatment of osteochondral lesions of the talus: A systematic review of clinical trials”. Journal of Orthopaedics 18 (2020): 218-225.
18. Repetto I., et al. “Conservative treatment of ankle osteoarthritis: can platelet-rich plasma effectively postpone surgery?”. The Journal of Foot and Ankle Surgery2 (2017): 362-365.
19. Binkley J M., et al. “The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network”. Physical Therapy 4 (1999): 371-383.